Progenitors to Peripheral Blood, The Journal of Experimental Medicine, vol.81, issue.1, pp.111-120, 1997. ,
DOI : 10.1038/382635a0
The chemokine SDF-1 stimulates integrin-mediated arrest of CD34+ cells on vascular endothelium under shear flow, Journal of Clinical Investigation, vol.104, issue.9, pp.1199-1211, 1999. ,
DOI : 10.1172/JCI7615
The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice, Blood, vol.95, pp.3289-3296, 2000. ,
Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: a possible role in homing of haemopoietic progenitor cells to bone marrow, British Journal of Haematology, vol.97, issue.4, pp.905-916, 1999. ,
DOI : 10.1146/annurev.physiol.57.1.827
CXCR4 acts as a costimulator during thymic ??-selection, Nature Immunology, vol.170, issue.2, pp.162-70, 2010. ,
DOI : 10.4049/jimmunol.170.1.421
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808461
Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice, Blood, vol.119, issue.24, pp.5722-5752, 2012. ,
DOI : 10.1182/blood-2012-01-403378
Maintenance of the Hematopoietic Stem Cell Pool by CXCL12-CXCR4 Chemokine Signaling in Bone Marrow Stromal Cell Niches, Immunity, vol.25, issue.6, pp.977-988, 2006. ,
DOI : 10.1016/j.immuni.2006.10.016
Reduced retention of radioprotective hematopoietic cells within the bone marrow microenvironment in CXCR4-/- chimeric mice, Blood, vol.107, issue.6, pp.2243-2251, 2006. ,
DOI : 10.1182/blood-2005-02-0581
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction, Blood, vol.112, issue.4, pp.990-998, 2008. ,
DOI : 10.1182/blood-2007-12-130179
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist, Blood, vol.102, issue.8, pp.2728-2730, 2003. ,
DOI : 10.1182/blood-2003-02-0663
Enhanced Unique Pattern of Hematopoietic Cell Mobilization Induced by the CXCR4 Antagonist 4F-Benzoyl-TN14003, STEM CELLS, vol.104, issue.(suppl 1), pp.2158-2166, 2007. ,
DOI : 10.1046/j.1365-2141.1999.01169.x
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4, Nature Immunology, vol.3, issue.7, pp.687-694, 2002. ,
DOI : 10.1038/ni813
Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and Galphai proteins and enhances engraftment of competitive, repopulating stem cells, Journal of Leukocyte Biology, vol.73, issue.5, pp.630-638, 2003. ,
DOI : 10.1189/jlb.1002495
Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival, Blood, vol.95, pp.756-768, 2000. ,
Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches, Nature, vol.495, issue.7440, pp.231-236, 2013. ,
DOI : 10.1182/blood-2004-01-0272
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600153
CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance, Nature, vol.170, issue.7440, pp.227-257, 2013. ,
DOI : 10.1179/014788899794813563
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600148
CXCR4/CXCL12 axis counteracts hematopoietic stem cell exhaustion through selective protection against oxidative stress, Scientific Reports, vol.996, issue.1, p.37827, 2016. ,
DOI : 10.1111/j.1749-6632.2003.tb03237.x
URL : https://hal.archives-ouvertes.fr/inserm-01472381
The leukemic stem cell niche: current concepts and therapeutic opportunities, Blood, vol.114, issue.6, pp.1150-1157, 2009. ,
DOI : 10.1182/blood-2009-01-202606
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723012
CXCR4 is a prognostic marker in acute myelogenous leukemia, Blood, vol.109, issue.2, pp.786-791, 2007. ,
DOI : 10.1182/blood-2006-05-024844
Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia, Blood, vol.104, issue.2, pp.550-557, 2004. ,
DOI : 10.1182/blood-2004-02-0566
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia, Blood, vol.119, issue.17, pp.3917-3941, 2012. ,
DOI : 10.1182/blood-2011-10-383406
CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model, Cell Death and Disease, vol.88, issue.10, p.396, 2012. ,
DOI : 10.1634/stemcells.2006-0468
URL : http://doi.org/10.1038/cddis.2012.137
Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy, Blood, vol.126, issue.2, pp.222-254, 2015. ,
DOI : 10.1182/blood-2015-02-628677
Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers, Antimicrobial Agents and Chemotherapy, vol.44, issue.6, pp.1667-1673, 2000. ,
DOI : 10.1128/AAC.44.6.1667-1673.2000
Advances in the assessment and control of the effector functions of therapeutic antibodies, Nature Reviews Drug Discovery, vol.45, issue.2, pp.101-111, 2011. ,
DOI : 10.1016/j.cyto.2008.11.008
NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy, Frontiers in Immunology, vol.6, 2015. ,
DOI : 10.3389/fimmu.2015.00368
URL : http://doi.org/10.3389/fimmu.2015.00368
Monoclonal antibodies in cancer therapy, Cancer Immun, vol.12, p.14, 2012. ,
High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia, British Journal of Haematology, vol.58, issue.3, pp.545-553, 2001. ,
DOI : 10.1038/31269
Identification of Hepatic Niche Harboring Human Acute Lymphoblastic Leukemic Cells via the SDF-1/CXCR4 Axis, PLoS ONE, vol.105, issue.11, 27042. ,
DOI : 10.1371/journal.pone.0027042.s007
Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities, Cell Stem Cell, vol.16, issue.3, pp.254-267, 2015. ,
DOI : 10.1016/j.stem.2015.02.014
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391962
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nature Medicine, vol.6, issue.7, pp.730-737, 1997. ,
DOI : 10.1128/MCB.6.9.3156
Leukemia Stem Cells in Acute Myeloid Leukemia, Seminars in Oncology, vol.35, issue.4, pp.326-361, 2008. ,
DOI : 10.1053/j.seminoncol.2008.04.003
Targeting the Acute Myeloid Leukemia Stem Cells, Anti-Cancer Agents in Medicinal Chemistry, vol.10, issue.2, pp.104-114, 2010. ,
DOI : 10.2174/187152010790909281
Hematopoietic Progenitor Cells, Stem Cells, vol.276, issue.6, pp.1015-1029, 2004. ,
DOI : 10.4049/jimmunol.169.12.7000
Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells, Blood, vol.112, issue.3, pp.568-575, 2008. ,
DOI : 10.1182/blood-2007-10-118331